RESUMO
Introduction Marine actinobacteria are promising sources of novel bioactive compounds due to their distinct ecological niches and diverse secondary metabolite production capabilities. Among these, Microbispora sp. T3S11 is notable for its unique spore chain structure, which allows for both morphological and genetic identification. Despite its potential, little is understood about the secondary metabolites produced by this strain. In this study, we hope to fill this gap by extracting and analyzing the antibacterial activities of secondary metabolites from Microbispora sp. T3S11, which will be the first time its bioactive compound profile is investigated. Aim To evaluate the antibacterial activity of secondary metabolites isolated from the marine actinobacterium Microbispora sp. T3S11. Materials and methods The antibacterial assays were carried out on agar plates containing the appropriate media for each pathogen. Sterile filter paper disks were impregnated with secondary metabolites extracted from Microbispora sp. T3S11 and placed on the surface of agar plates inoculated with the appropriate pathogens. Similarly, disks containing tetracycline were used as a positive control. The plates were then incubated at the appropriate temperature for each pathogen, and the zones of inhibition around the disks were measured to determine the extracted metabolites' antibacterial activity. Result Secondary metabolites had antimicrobial activity against Streptococcus mutans, Klebsiella pneumonia, and methicillin-resistant Staphylococcus aureus (MRSA). The inhibition of S. mutans was 7.5 mm and 8.5 mm at 75 µg/mL and 100 µg/mL, respectively. Klebsiella pneumonia zones measured 7 mm and 7.5 mm, while MRSA zones measured 7.6 mm and 8.5 mm at the same concentrations. Tetracycline, the standard antibiotic, had larger inhibition zones: 22 mm for S. mutans and Klebsiella pneumonia and 16 mm for MRSA, indicating variable susceptibility. Conclusion We conclude that the secondary metabolites extracted from Microbispora sp. T3S11 exhibits high antibacterial activity. This could be attributed to the presence of various active compounds.
RESUMO
BACKGROUND: - Camellia sinensis, or oolong tea, is a partially fermented version of tea used in Asian countries. The remarkable reduction activity of the tea extract can potentially be used for synthesizing nanoparticles. Recently, Camellia sinensis has gained popularity for the formulation of some metal nanoparticles. Aim To formulate green synthesis of copper oxide nanoparticles (CuONPs) mediated by Camellia sinensis (oolong tea) and assess its cytotoxicity and antioxidant properties. Materials & Methods Oolong tea extract is prepared and added to CuSO4 solution to synthesize CuO nanoparticles (CuONPs). The centrifugation pellet of CuONPs is collected and subjected to DPPH (2,2 - diphenyl -1- picrylhydrazyl hydrate) and H2O2 assays. The cytotoxicity screening is performed using zebrafish embryos. Results The reducing activity of oolong tea successfully synthesizes the copper nanoparticles. High values are obtained in DPPH (63% inhibition at 10µL concentration, 73% inhibition at 20µL, 80% at 30µL, 85% at 40µL and 90% at 50µL concentrations) and H2O2 (50% inhibition at 10µL concentration, 65% at 20µL, 68% at 30µL, 75% at 40µL and 80% at 50µL concentrations) assays. There are no morphological deformities in the zebrafish and no loss of cell viability or delayed hatching at low concentrations (below 4-8 µL), as shown by the viable embryos with no morphological deformities. Conclusion The study has evidenced high antioxidant activity and minimal cytotoxicity of CuO nanoparticles produced using Camellia sinensis, thus proving it to be a good biomaterial for a wide range of biological applications.
